Abeona Therapeutics Inc vs Micron Technology, Inc. — how do they compare? Abeona Therapeutics Inc trades at $7.57 (market cap $421.19M), while Micron Technology, Inc. trades at $890.8 (market cap $980.90B). The key difference: Micron Technology, Inc. is far larger — about 2328.9× Abeona Therapeutics Inc's market cap, and Micron Technology, Inc. pays a 0.06% dividend while Abeona Therapeutics Inc pays none. Which is the better fit depends on your goals.
| ABEO | MU | |
|---|---|---|
Market Cap | $421.19M | $980.90B |
Sector | Health | Technology |
52-Week High | $7.45 | $1.21K |
52-Week Low | $4.17 | $115.79 |
Enterprise Value | $276.10M | $961.25B |
Dividend Yield | — | 0.06% |
Trailing returns across standard periods
Latest headlines on both assets
Abeona Therapeutics develops gene and cell therapies for rare diseases. Its lead product, ZEVASKYN, is an FDA-approved therapy for recessive dystrophic epidermolysis bullosa (RDEB), a severe and life-threatening genetic skin disorder.
Read more on ABEO →Micron historically focused on designing and manufacturing DRAM for PCs. The firm then expanded into the NAND flash memory market. It increased its DRAM scale with the purchase of Elpida (completed in mid-2013) and Inotera (completed in December 2016). The firm's DRAM and NAND products tailored to PCs, data centers, smartphones, game consoles, automotives, and other computing devices.
Read more on MU →